Byetta vs Lyxumia
Quick Facts
- Type: GLP-1
- FDA Approval: Byetta (2005), Lyxumia (2016)
- Frequency: Twice daily
Weight Loss Data
- Byetta: 2-6% in 30 weeks
- Lyxumia: 2-4% in 24 weeks
Primary Uses
- •Type 2 Diabetes
Medication Overview
Byetta
GLP-1Basic Information
- Generic Name: exenatide
- Manufacturer: AstraZeneca
- FDA Approval: 2005
Key Benefits
- ✓Established safety profile
- ✓May reduce post-meal blood sugar spikes
- ✓Weight loss support
- ✓Long-term clinical experience
Lyxumia
GLP-1Basic Information
- Generic Name: lixisenatide
- Manufacturer: Sanofi
- FDA Approval: 2016
Key Benefits
- ✓Once-daily dosing
- ✓Reduces post-meal glucose levels
- ✓Simple titration schedule
- ✓Can be used with basal insulin
Dosing Information
| Dosing Details | Byetta | Lyxumia |
|---|---|---|
| Starting Dose | 5mcg | 10mcg |
| Maintenance Dose | 10mcg | 20mcg |
| Maximum Dose | 10mcg | 20mcg |
| Schedule | Inject twice daily within 60 minutes before morning and evening meals | Inject once daily within one hour before the first meal of the day |
| Titration | Start with 5mcg twice daily for at least one month before increasing to 10mcg twice daily | Start with 10mcg daily for 14 days, then increase to 20mcg daily |
Side Effects
Byetta
- •Nausea
- •Vomiting
- •Diarrhea
- •Feeling Jittery
- •Dizziness
- •Headache
Lyxumia
- •Nausea
- •Vomiting
- •Diarrhea
- •Headache
- •Dizziness
- •Injection Site Reactions
Practical Information
Byetta
Storage & Handling
- Storage: Refrigerate until first use, then can be stored at room temperature for up to 30 days
- Needle Info: Requires separate pen needles
Insurance & Coverage
Generally covered for diabetes treatment
Clinical Results
- Weight Loss: 2-6%
- Study Duration: 30 weeks
- Study: Original clinical trials
Lyxumia
Storage & Handling
- Storage: Refrigerate until first use, then can be stored at room temperature for up to 14 days
- Needle Info: Requires separate pen needles
Insurance & Coverage
Coverage varies by region and insurance plan
Clinical Results
- Weight Loss: 2-4%
- Study Duration: 24 weeks
- Study: GetGoal clinical trial program
Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.
Track Your GLP-1 Journey with ShotWise
Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.
Download ShotWise